A Phase 3, Randomized, Double-blind, Double-dummy, Comparative Study of LX-P in Patients with Chronic Low Back Pain (BRAND)

Trial Profile

A Phase 3, Randomized, Double-blind, Double-dummy, Comparative Study of LX-P in Patients with Chronic Low Back Pain (BRAND)

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Loxoprofen (Primary) ; Loxoprofen
  • Indications Back pain
  • Focus Therapeutic Use
  • Acronyms BRAND
  • Sponsors Lead Chemical
  • Most Recent Events

    • 08 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top